Top Consumer Driven Health Care Stories
CVS Caremark sued over GLP-1 drug switch, citing ERISA breach
By Alan GoforthA class-action lawsuit was filed last week against CVS Caremark in the Southern District of New York over its decision to replace Eli Lilly's popular GLP-1 weight-loss drug Zepbound with Wegovy from Novo Nordisk.




